The initial investment in mRNA Vaccines for GOAL 2050 will be generated from private investment in the Normax AAA mRNA Vaccine Bond up to eight hundred million dollars.
The AAA bond finance will be used for development and manufacturing of transformative mRNA vaccines in the new UKvax Factory with modular localized mRNA vaccine factory scaling.
The new GOAL 2050 campaign is planned in cooperation with the mRNA Vaccine Consortium and Global Public Health Stakeholders.
NOT AN OFFER TO INVEST. PROFESSIONAL INVESTORS ONLY. SEE RED HERRING.